Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment ...

PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 95% based on the firm’s underlying fundamentals and the stock’s valuation.

PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 90% based on the firm’s underlying fundamentals and the stock’s valuation.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...

Investors in Pfizer Inc. (NYSE:PFE) need to pay close attention to the stock based on moves in the options market lately. That... One stock that might be an intriguing choice for investors right ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

VBI Vaccines (NASDAQ:VBIV) Inc. VBIV announced an update on the progress of its two vaccine candidates for COVID-19. The first ...

Our analysis is essentially based on ... in earnings estimate revisions and short-term stock price movements. For the current quarter, Pfizer is expected to post earnings of $0.67 per share ...

The city’s pharma giants avoided much of the initial turbulence felt by the rest of the economy in the wake of President Donald Trump’s sweeping tariffs. The S&P 500 cratered Thursday following news ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $152.57, a high ...